Ramy Farid

Dr. Ramy Farid is an Independent Director at Vir Biotechnology, Inc., a President, Chief Executive Officer & Director at Schrödinger, Inc. and a President at Schrodinger, Inc. (Oregon).
He is on the Board of Directors at Vir Biotechnology, Inc., Oak Hill Bio Corp., Ajax Therapeutics, Inc., Schrödinger, Inc., Nimbus Apollo, Inc. and Shanghai ShouTi Biotechnology Co. Ltd. Dr. Farid was previously employed as an Independent Director by Structure Therapeutics, Inc., a Co-Founder by Nimbus Therapeutics LLC, and an Assistant Professor by Rutgers State University of New Jersey.
He also served on the board at Morphic Holding, Inc., Morphic Therapeutic, Inc. and Nimbus Therapeutics LLC.
He received his undergraduate degree from Rochester Christian University, a doctorate degree from the University of Pennsylvania and a doctorate degree from California Institute of Technology.